Zura Bio Ltd
Zura Bio Ltd is listed today as Zura Bio Ltd: market value, financials and filings are on its company page.
Funding rounds
1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Apr 2024 | $113 M | Private placement after listing | $50 to $250 million | equity, options | SEC | |
| May 2023 | $16 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Zura Bio Ltd chose not to state its revenue in its newest notice of a funding round (May 2024).
SEC Form D · May 2024
The industry group it chose in its notices: Biotechnology.
SEC Form D · May 2024
That is all the official record says: Zura Bio Ltd has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Zura Bio Ltd are on record.
Investors#
No investor of Zura Bio Ltd is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 21 investors.
Largest shareholders today
Institutions holding Zura Bio Ltd shares, as of Sep 30, 2026.
- Montanova Capital, LLC$39 M9.80%
- Venrock Adviser, LLC$27 M6.68%
- MPM Bioimpact LLC$19 M4.62%
- Great Point Partners LLC$17 M4.23%
- Siren, L.L.C.$16 M3.88%
- BlackRock, Inc.$15 M3.84%
- Commodore Capital LP$14 M3.37%
- Braidwell LP$11 M2.75%
- Adage Capital Partners GP, L.L.C.$9 M2.34%
- Saturn V Capital Management LP$8 M2.11%
- Vestal Point Capital, LP$8 M1.93%
- Foresite Capital Management VI LLC$7 M1.82%
- Armistice Capital, LLC$7 M1.80%
- QVT Financial LP$7 M1.73%
- Geode Capital Management, LLC$6 M1.56%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Gary Whale | Executive officer | May 2024 |
| Kim Davis | Executive officer | May 2024 |
| Kiran Nistala | Executive officer | May 2024 |
| Michael Howell | Executive officer | May 2024 |
| Robert Lisicki | Executive officer | May 2024 |
| Verender Badial | Executive officer | May 2024 |
| Christopher Cabell | Executive officer | May 2023 |
| Someit Sidhu | Executive officer | May 2023 |
| Amit Munshi | Director | May 2024 |
| Arnout Ploos van Amstel | Director | May 2024 |
| Jennifer Jarrett | Director | May 2024 |
| Neil Graham | Director | May 2024 |
| Parvinder Thiara | Director | May 2024 |
| Robert Lisicki | Director | May 2024 |
| Sandeep Kulkarni | Director | May 2024 |
| Someit Sidhu | Director | May 2024 |
| Steven Schoch | Director | May 2024 |
| Garry Neil | Director | May 2023 |
Went public since 2023. Its SEC number is that of a company listed on a stock exchange.